In situ product removal using a crystallization loop in asymmetric reduction of 4-oxoisophorone by Saccharomyces cerevisiae

Biotechnology and Bioengineering

Volumn 86, Issue 7, 2004, Pages 795-800

  Buque Taboada, Evelyn M ^a,b   Straathof, Adrie J J ^a   Heijnen, Joseph J ^a   Van Der Wielen, Luuk A M ^a,b  

^a DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b UNIVERSITY OF SAN CARLOS   (Philippines)

Author keywords

4 oxoisophorone; Baker's yeast; Bioreduction; Crystallization; In situ product removal

Indexed keywords

ALCOHOLS; BIOCATALYSTS; BIOSYNTHESIS; CRYSTALLIZATION; FERMENTATION; REDUCTION; YEAST;

ACTINOL FORMATION;

BIOCHEMICAL ENGINEERING;

4 OXOISOPHORONE; ACTINOL; ALCOHOL DERIVATIVE; CAROTENOID; DIHYDROOXOISOPHORONE; ISOPHORONE; LEVODIONE; ORGANIC SOLVENT; UNCLASSIFIED DRUG;

ARTICLE; BATCH PROCESS; BIOCATALYST; CONCENTRATION (PARAMETERS); CRYSTALLIZATION; DEGRADATION; DISSOLUTION; FERMENTATION; NONHUMAN; PURIFICATION; REDUCTION; SACCHAROMYCES CEREVISIAE; SOLID; WASTE MINIMIZATION;

BIOTRANSFORMATION; CRYSTALLIZATION; CYCLOHEXANONES; FERMENTATION; OXIDATION-REDUCTION; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 2942586917     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.20093     Document Type: Article

References (34)

1. Bao J, Koumatsu K, Furumoto K, Yoshimoto M, Fukunaga K, Nakao K. 2001. Optimal operation of an integrated bioreaction-crystallization process for continuous production of calcium gluconate using external loop airlift columns. Chem Eng Sci 56:6165-6170.
2. Blacker AJ, Holt RA. 1997. Development of a multi-stage chemical and biological process for an optically active intermediate for an antiglaucoma drug. In: Collins AN, Sheldrake GN, Crosby J, editors. Chirality in industry II. Chichester, UK: John Wiley & Sons. p 245-261.
3. Buque EM, Chin-Joe I, Straathof AJJ, Jongejan JA, Heijnen JJ. 2002. Immobilization affects the rate and enantioselectivity of 3-oxo ester reduction by baker's yeast. Enz Microb Technol 31:656-664.
4. Cardoso JP. 1993. A simple model for the optimization of the extraction yield of antibiotics isolated from fermented broths by direct crystallization. Biotechnol Bioeng 42:1068-1076.
5. Chartrain M, Roberge C, Chung J, McNamara J, Zhao DL, Olewinski R, Hunt G, Salmon P, Roush D, Yamazaki S, Wang T, Grabowski E, Buckland B, Greasham R. 1999. Asymmetric bioreduction of (2-(4-nitro-phenyl)-N-(2-oxo-2-pyridin-3-yl-ethyl)-acetamide) to its corresponding (R) alcohol [(R)-N-(2-hydroxy-2-pyridin-3-yl-ethyl)-2-(4-nitro-phenyl))-acetamide] by using Candida sorbophila MY 1833. Enzyme Microb Technol 25:489-496.
6. Chin-Joe I, Nelisse PM, Straathof AJJ, Jongejan JA, Pronk JT, Heijnen JJ. 2000. Hydrolytic activity in baker's yeast limits the yield of asymmetric 3-oxo ester reduction. Biotechnol Bioeng 69:370-376.
7. Chin-Joe I, Straathof AJJ, Pronk JT, Jongejan JA, Heijnen JJ. 2001. Influence of the ethanol and glucose supply rate on the rate and enantioselectivity of 3-oxo ester reduction by baker's yeast. Biotechnol Bioeng 75:29-38.
8. Chin-Joe I, Straathof AJJ, Pronk JT, Jongejan JA, Heijnen JJ. 2002. Effect of high product concentration in a dual fed-batch asymmetric 3-oxo ester reduction by baker's yeast. Biocatal Biotransform 20:337-345.
9. Crocq V, Masson C, Winter J, Richard C, Lemaitre G, Lenay J, Vivat M, Buendia J, Prat D. 1997. Synthesis of trimegestone: the first industrial application of baker's yeast mediated reduction of a ketone. Org Proc Res Dev 1:2-13.
10. D'Arrigo P, Pedrocchi-Fantoni G, Servi S. 1997. Old and new synthetic capacities of baker's yeast. Adv Appl Microbiol. 44:81-123.
11. Freeman A, Lilly MD. 1998. Effect of processing parameters on the feasibility and operational stability of immobilized viable microbial cells. Enz Microb Technol 23:335-345.
12. Freeman A, Woodley JM, Lilly MD. 1993. In situ product removal as a tool for bioprocessing. Biotechnology 11:1007-1012.
13. Furui M, Sakata N, Otsuki O, Tosa T. 1988. A bioreactor-crystallizer for L-malic acid production. Biocatalysis 2:69-77.
14. Hurh B, Ohsima M, Yamane T, Nagasawa T. 1994. Microbial production of 6-hydroxynicotinic acid, an important building block for the synthesis of modern insecticides. J Ferment Bioeng 77:382-385.
15. Kaščá JS, Kominek J, Roehr M. 1996. Lactic acid. In: Roehr M, editor. Biotechnology, vol. 4, 2nd ed. Weinheim: VCH. p 293-306.
16. Leuenberger HGW, Boguth W, Widmer E, Zell R. 1976. Synthesis of optically active natural carotenoids and structurally related compounds. 1. Synthesis of the chiral key compound (4R,6R)-4-hydroxy-2,2,6-trimethylcyclohexanone. Helv Chim Acta 59:1832-1849.
17. Leuenberger HGW. 1985. Microbiologically catalyzed reaction steps in the field of vitamin and carotenoid synthesis. In: Tramper J, van der Plas HC, Linko P, editors. Biocatalysts in organic synthesis. Amsterdam: Elsevier. p 99-118.
18. Lye GJ, Woodley JM. 1999. Application of in situ product-removal techniques to biocatalytic processes. Trends Biotechnol 17:395-402.
19. Matsumae H, Akatsuka H, Shibatani T. 1999. Diltiazem synthesis. In: Flickinger MC, Drew SJ, editors. Encyclopedia of bioprocess technology. New York: John Wiley & Sons. p 823-840.
20. Miller TL. 1985. Steroid fermentations. In: M. Moo-Young M, editor. Comprehensive biotechnology. Oxford, UK: Pergamon Press. p 297-318.
21. Nakayama K. 1985. Tryptophan. In: Moo-Young M, editor. Comprehensive biotechnology. Oxford, UK: Pergamon Press. p 621-631.
22. Schügerl K. 2000. Integrated processing of biotechnology products. Biotechnol Adv 18:581-599.
23. Sode K, Kajiwara K, Tamiya E, Karube I. 1987. Continuous asymmetric reduction of 4-oxoisophorone by thermophilic bacteria using a hollow fiber reactor. Biocatalysis 1:77-86.
24. Stark D, Jaquet A, von Stockar U. 2003. In-situ product removal (ISPR) in whole cell biotechnology during the last 20 years. Adv Biochem Eng Biotechnol 80:149-175.
25. Sybesma WFH, Straathof AJJ, Jongejan JA, Heijnen JJ. 1998. Reductions of 3-oxo esters by baker's yeast: current status. Biocatal Biotransform 16:95-134.
26. Takamatsu S, Ryu DDY. 1988a. Recirculating bioreactor-separator system for simultaneous biotransformation and recovery of product: immobilized L-aspartate β-decarboxylase reactor system. Biotechnol Bioeng 32:184-191.
27. Takamatsu S, Ryu DDY. 1988b. New recirculating bioreactor-separator combination system for continuous bioconversion and separation of products. Enz Microb Technol 10:593-600.
28. Tosa T, Furui M, Sakata N, Otsuki O, Chibata I. 1988. Design of a bioreactor using immobilized biocatalysts for the slurry reaction: production of L-malic acid. Ann NY Acad Sci 542:440-443.
29. van der Wielen LAM, Luyben KCAM. 1992. Integrated product formation and recovery in fermentation. Review. Curr Opin Biotechnol 3:130-138.
30. van Loon APGM, Hohmann HP, Bretzel W, Hübelin M, Pfister M. 1996. Development of a fermentation process for the manufacture of riboflavin. Chimia 50:410-412.
31. Wada M, Yoshizumi A, Nakamori S, Shimizu S. 1999. Purification and characterization of monovalent cation-activated reductase from Corynebacterium aquaticum M-13. Appl Environ Microbiol 65:4399-4403.
32. Wada M, Yoshizumi A, Noda Y, Kataoka M, Shimizu S, Takagi H, Nakamori S. 2003. Production of a doubly chiral compound, (4R,6R)-4-hydroxy-2,2,6-trimethylcyclohexanone, by two-step enzymatic asymmetric reduction. Appl Environ Microbiol 69:933-937.
33. Wanner P, Tressl R. 1998. Purification and characterization of two enone reductases from Saccharomyces cerevisiae. Eur J Biochem 255:271-278.
34. Yoshisumi A, Wada M, Takagi H, Shimizu S, Nakamori S. 2001. Cloning, sequence analysis, and expression in Escherichia coli of the gene encoding monovalent cation-activated levodione reductase from Corynebacterium aquaticum M-13. Biosci Biotechnol Biochem 65:830-836.